Cancer Research
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Inceptor Bio
PR-M06-21-018Jun 14, 2021
Cell Line Development
Rising Demand for Novel Cancer Treatment Approaches to Propel Cell Line Development Market through 2024
Global Market Insights
PAO-M11-19-NI-007Nov 20, 2019
Tumor Microenvironment
Focusing on the Tumor Microenvironment Leads to Novel Drug Targets
Shaan C. Gandhi, M.D., Ph.D.
Pyxis Oncology
PAP-Q3-19-CL-023Oct 28, 2019
Novel Therapies
Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?
Pharma's Almanac
PAP-Q2-2019-NI-007May 23, 2019
Novel Therapy
Novel Combination Therapy Promotes Wound Healing
Albert Einstein College of Medicine
PR-M10-18-NI-096Oct 29, 2018
Drug Development
First Light Biosciences Develops a Novel Method for Rapidly Determining Effective Antibiotics for Treating Infections
First Light Biosciences:
PR-M10-18-NI-010Oct 02, 2018
Artificial Intelligence
AI-Guided Cancer Therapy Platform from SRI International Identifies Novel Molecular Targets for Aggressive Form of Breast Cancer
SRI Biosciences
PR-M04-18-NI-71Apr 20, 2018
Immuno-Oncology
FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies
FIMECS, Inc.
PR-M04-18-NI-44Apr 13, 2018
Fast Track
Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients
Biostage, Inc.
PR-M04-18-NI-002-4473Apr 02, 2018
Drug Development
Celgene, Vividion Therapeutics Collaborate on Novel Protein Drugs
Guy Tiene
Nice Insight
PAO-M03-18-NI-005Mar 08, 2018
Clinical Trials
Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)
Rexgenero
PR-M01-18-NI-093Jan 30, 2018
CFDA
China FDA Publishes Guidance for Priority Review
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-013Jan 09, 2018
Strategic Partnership
Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases
Nice Insight
PAO-M11-17-NI-022Nov 14, 2017